Pacific Biosciences of California Overview
Pacific Biosciences of California Target Price
Analysts' 12-month price predictions for PACB.
Get informed when a big investor buys or sells
+ FollowShare Price
$1.58
Average Target Price
$1.00
36.7% downside
36.7% downside1 analysts in the last 4 months
High: $1 | Low: $1
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-04-14 | Barclays | $1 | 36.7% downside |  |
| 2025-08-08 | BernsteinEve Burstein | $1.7 |  7.6% upside | |
| 2025-06-25 | BarclaysLuke Sergott | $1.5 | 5.1% downside | |
| 2024-06-03 | JefferiesTycho Peterson | $4 | 153.2% upside | |
| 2024-05-13 | Morgan StanleyTejas Savant | $4 | 153.2% upside | |
| 2024-05-13 | Piper SandlerDavid Westenberg | $2 | 26.6% upside | |
| 2024-05-10 | BarclaysLuke Sergott | $2 | 26.6% upside | |
| 2024-04-18 | Goldman SachsMatthew Sykes | $2.5 | 58.2% upside | |
| 2024-04-16 | Canaccord GenuityKyle Mikson | $3.5 | 121.5% upside | |
| 2022-11-16 | Canaccord Genuity | $14 | 786.1% upside | |
| 2022-08-17 | Piper SandlerDavid Westenberg | $7.5 | 374.7% upside | |
| 2022-05-15 | Piper SandlerDavid Westenberg | $6 | 279.7% upside | |
| 2022-01-12 | Piper SandlerDavid Westenberg | $20 | 1165.8% upside | |